WO2005011593A3 - Liaison amelioree du pantoprazole et de la pompe a acide - Google Patents

Liaison amelioree du pantoprazole et de la pompe a acide Download PDF

Info

Publication number
WO2005011593A3
WO2005011593A3 PCT/US2004/024678 US2004024678W WO2005011593A3 WO 2005011593 A3 WO2005011593 A3 WO 2005011593A3 US 2004024678 W US2004024678 W US 2004024678W WO 2005011593 A3 WO2005011593 A3 WO 2005011593A3
Authority
WO
WIPO (PCT)
Prior art keywords
pantoprazole
improved binding
acid pump
acid
pump
Prior art date
Application number
PCT/US2004/024678
Other languages
English (en)
Other versions
WO2005011593A2 (fr
Inventor
Richard J Heaslip
Original Assignee
Altana Pharma Ag
Richard J Heaslip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag, Richard J Heaslip filed Critical Altana Pharma Ag
Publication of WO2005011593A2 publication Critical patent/WO2005011593A2/fr
Publication of WO2005011593A3 publication Critical patent/WO2005011593A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une certaine forme de pantoprazole se liant sélectivement à la pompe à protons, ce qui permet d'améliorer le degré et la durée d'une inhibition d'acide.
PCT/US2004/024678 2003-07-31 2004-07-30 Liaison amelioree du pantoprazole et de la pompe a acide WO2005011593A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49127303P 2003-07-31 2003-07-31
US60/491,273 2003-07-31

Publications (2)

Publication Number Publication Date
WO2005011593A2 WO2005011593A2 (fr) 2005-02-10
WO2005011593A3 true WO2005011593A3 (fr) 2005-09-01

Family

ID=34115485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/024678 WO2005011593A2 (fr) 2003-07-31 2004-07-30 Liaison amelioree du pantoprazole et de la pompe a acide

Country Status (1)

Country Link
WO (1) WO2005011593A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102786483B (zh) * 2011-05-19 2016-03-30 复旦大学 4-(4-苯基哌嗪基)喹唑啉类衍生物的药用用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025028A1 (fr) * 1993-04-27 1994-11-10 Sepracor, Inc. Procedes et compositions de traitement de troubles gastriques a l'aide de pantoprazole (+) optiquement pur

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025028A1 (fr) * 1993-04-27 1994-11-10 Sepracor, Inc. Procedes et compositions de traitement de troubles gastriques a l'aide de pantoprazole (+) optiquement pur

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CURRENT OPINION IN GASTEROENTEROLOGY, vol. 19, no. 6, 2003, pages 519 - 525 *
DATABASE BIOBASE [online] SCHUBERT M.K. ET AL: "Gastric Secretion", accession no. STN Database accession no. (2003267791) *

Also Published As

Publication number Publication date
WO2005011593A2 (fr) 2005-02-10

Similar Documents

Publication Publication Date Title
WO2003059251A3 (fr) Composes de ciblage d'anticorps
WO2006007207A3 (fr) Procedes et dispositifs pour la determination de sequence d'acides nucleiques
WO2007024705A3 (fr) Procede de traitement de la depression au moyen d'un anticorps anti-tnf-alpha
WO2006023651A3 (fr) Traitement prolonge de la sclerose en plaques
WO2006037811A3 (fr) Composes d'exendin-4 a action prolongee
WO2009052431A3 (fr) Agents de liaison au cd19 et utilisations de ceux-ci
WO2006034035A3 (fr) Traitement de l'ischemie
WO2005075412A3 (fr) Composes cycloaliphatiques a base de norbonane contenant des groupes nitriles
WO2006039250A3 (fr) Sels de compose heterocyclique se liant aux chimiokines et procedes d'utilisation correspondants
ZA200208489B (en) Salt-sensitive, water-dispersible polymer composition.
WO2003093472A3 (fr) Acides nucleiques liant le cgrp
WO2006029398A8 (fr) Tout-trans-retinol:tout-trans-13,14-dihydroretinol saturase et procedes d'utilisation de cette enzyme
WO2004032908A3 (fr) Methode d'inhibition de l'angiogenese
WO2004075021A3 (fr) Procedes de modelisation moleculaire
WO2006014877A3 (fr) Inhibiteurs de canaux potassiques
WO2003066097A3 (fr) Nouvelle cible pour inhiber l'angiogenese
WO2006023586A3 (fr) Composes de guanylhydrazone, compositions de guanylhydrazone, ainsi que leurs methodes de fabrication
WO2004098599A3 (fr) Agents pour le traitement de troubles du bas-ventre
WO2004013274A3 (fr) Acides nucleiques a liaison de ghreline
IL173654A0 (en) 1-carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof
WO2006004613A3 (fr) Sels de guanylhydrazone, compositions a base de ceux-ci, procedes et production et d'utilisation de ceux-ci
WO2004092481A3 (fr) Procede de traitement de surfaces de papier
WO2005034840A3 (fr) Identification d'inhibiteurs de kinase
WO2005011593A3 (fr) Liaison amelioree du pantoprazole et de la pompe a acide
WO2008028032A3 (fr) Hydantoïnes substituées, thérapeutiques, et composés associés

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase